Study Ties Asthma to Higher Odds for Diabetes, Heart Disease – U.S. News & World Report

Study Ties Asthma to Higher Odds for Diabetes, Heart Disease
U.S. News & World Report
SUNDAY, March 20 (HealthDay News) — People with asthma may have a higher risk of developing diabetes and heart disease, according to a new study that looked at the relationship between asthma and four other inflammatory conditions.
Asthma Associated with Increased Risk of Diabetes, Heart DiseaseHealthCanal.com
Could Differences In Lung Defects Be Linked To Gender?Medical News Today (press release)
Revalesio To Present Research On The Anti-Inflammatory Effects Of RNS60 In AsthmaBiomed Middle East
KBOI –Shreveport Times –TopNews United States
all 29 news articles »

View full post on asthma – Google News

Xolair Reduces Seasonal Asthma Attacks for Inner City Kids: Study – BusinessWeek


LiveScience.com

Xolair Reduces Seasonal Asthma Attacks for Inner City Kids: Study
BusinessWeek
WEDNESDAY, March 16 (HealthDay News) — The injectable medication Xolair reduced asthma symptoms in inner city children with the respiratory condition, and almost eliminated seasonal peaks in asthma attacks, new research shows.
Study Finds Adult Asthma Drug Dramatically Reduces Seasonal Attacks in KidsMyFox Washington DC
Asthma Worse In Children, Novartis' Xolair RecommendedMedical News Today
New study finds ways to help curb asthma among urban childrenSuperior Telegram
Sify –Clinical Advisor –msnbc.com
all 79 news articles »

View full post on asthma – Google News

Study Finds Adult Asthma Drug Dramatically Reduces Seasonal Attacks in Kids – MyFox Washington DC


LiveScience.com

Study Finds Adult Asthma Drug Dramatically Reduces Seasonal Attacks in Kids
MyFox Washington DC
(NewsCore) – An asthma drug approved for teens and adults nearly eliminated seasonal increases in asthma attacks and asthma symptoms among children living in inner-city environments, according to research released Thursday by the National Institutes of
Asthma Worse In Children, Novartis' Xolair RecommendedMedical News Today
New study finds ways to help curb asthma among urban childrenSuperior Telegram
Omalizumab 'cuts seasonal asthma attacks in youth'Sify
Clinical Advisor –msnbc.com –MedPage Today
all 62 news articles »

View full post on asthma – Google News

New study finds ways to help curb asthma among urban children – Superior Telegram


LiveScience.com

New study finds ways to help curb asthma among urban children
Superior Telegram
A nationwide study led by a UW-Madison doctor shows a new way to stop seasonal asthma attacks for some of the hardest-to-treat cases, namely kids in urban areas. A nationwide study led by a UW-Madison doctor shows a new way to stop seasonal asthma
Asthma Worse In Children, Novartis' Xolair RecommendedMedical News Today
Omalizumab 'cuts seasonal asthma attacks in youth'Sify
Omalizumab improves asthma control in inner-city childrenClinical Advisor
msnbc.com –MedPage Today –WebMD
all 55 news articles »

View full post on asthma – Google News

Xolair Relieves Kids’ Seasonal Asthma Attacks: Study – WebMD

Xolair Relieves Kids' Seasonal Asthma Attacks: Study
WebMD
March 16, 2011 — The asthma drug Xolair (omalizumab) improves asthma control, nearly eliminates seasonal flare-ups, and allows reductions in the doses of other asthma control medications in children as young as 6, according to a new
Novartis, Roche's Xolair Helps Stop Asthma Attacks in ChildrenBloomberg

all 2 news articles »

View full post on asthma – Google News